Search

Charles L. Sawyers has been elected a member of the Institute of Medicine of the National Academies.

… Monday, December 1, 2008 Summary Charles L. Sawyers has been elected a member of the Institute of Medicine of the National Academies. Charles L. Sawyers has been elected a member of the Institute of Medicine of the National Academies. Dr. Sawyers is a nationally recognized physician-scientist who joined

Meet Christopher Jeter, who was diagnosed nearly 10 years ago with lung cancer. He was successfully treated at Memorial Sloan Kettering and now is being closely monitored by experts in MSK's Adult Survivorship Program.

… Monday, June 14, 2021 Getting hit by a bus saved Christopher Jeter’s life. In 2011, when the 54-year-old inventory manager took his brand-new motorcycle for a spin, he collided with a public transit bus. Incredibly, he left the scene mostly unscathed. But doctors in the emergency room near his home in

Conozca a Christopher Jeter, quien fue diagnosticado hace casi 10 años con cáncer pulmonar. Fue tratado con éxito en Memorial Sloan Kettering y ahora está siendo monitoreado de cerca por expertos en el Programa de Sobrevivencia para Adultos de MSK.

… Monday, June 14, 2021 Ser atropellado por un autobús le salvó la vida a Christopher Jeter. En 2011, cuando el gerente de inventario de 54 años salió a probar su motocicleta nueva, chocó con un autobús de transporte público. Increíblemente, salió del accidente casi ileso. Pero los médicos en la sala de

Results from a clinical trial indicate that an experimental CAR therapy for mesothelioma is safe.

… Sunday, March 31, 2019 Summary Scientists at Memorial Sloan Kettering are investigating ways to develop effective CAR T cell therapies for solid tumors. Results from a clinical trial in people with mesothelioma indicate that an experimental CAR therapy is safe and may provide benefit to patients, especially

Collaboration leads to a new digital pathology tool that allows some doctors to diagnose patient tumors from home.

… Monday, September 21, 2020 Summary MSK’s Pathology Department has developed new digital technologies to keep its workers safe without having to compromise patient care — allowing some of its doctors to work from home. During the COVID-19 pandemic, Memorial Sloan Kettering doctors and nurses have been

Learn about larotrectinib, the first cancer drug to be FDA approved for adult and pediatric patients at the same time.

… Monday, November 26, 2018 Summary Larotrectinib is the first cancer drug to be FDA approved based on its effect on a specific mutation in a tumor. The US Food and Drug Administration has approved the drug larotrectinib (Vitrakvi®; LOXO-101) for cancers caused by a genetic mutation called a TRK fusion

This study demonstrates how clonal hematopoiesis (CH)–derived mutations could lead to erroneous reporting and treatment recommendations when tumor-only sequencing is employed. If data about the blood are not part of test results, mutations present in the blood may be misread as mutations in the tumor, which can potentially affect the therapies patients receive. Data presented at the annual meeting of the American Society of Clinical Oncology by Ahmet Zehir, PhD, Director of Clinical Bioinformatics at Memorial Sloan Kettering Cancer Center (MSK) was simultaneously published in JAMA Oncology on June 5.

… Tuesday, June 5, 2018 Bottom Line: This study demonstrates how clonal hematopoiesis (CH)–derived mutations could lead to erroneous reporting and treatment recommendations when tumor-only sequencing is employed. If data about the blood are not part of test results, mutations present in the blood may be

In an international study led by MSK, researchers reported finding key mutations driving the disease histiocytosis for nearly all of the people included.

… Wednesday, December 4, 2019 Summary In an international study led by MSK, researchers reported finding key mutations driving the disease histiocytosis for nearly all of the people included. Histiocytoses are a group of blood diseases that are diagnosed in only a few hundred people in the United States

Infectious disease expert Mini Kamboj shares what people with cancer should know about COVID-19 and how MSK is keeping our patients and staff safe

… Wednesday, April 1, 2020 By Jim Stallard This story was updated on April 27, 2020. COVID-19 emerged as a major threat to public health in the United States in early 2020. Memorial Sloan Kettering Chief Medical Epidemiologist and infectious disease expert Mini Kamboj shares some facts about COVID-19,

Recent advances in epigenetic and targeted therapies owe a lot to the foresight of former MSK President Paul Marks, who believed in the importance of basic research.

… Friday, November 10, 2017 Picture of the Paul Marks Prize medal The Paul Marks Prize is awarded every other year to scientists who have made important contributions early in their careers. Paul Marks (left) and Laurance Rockefeller at the Rockefeller Research Laboratories groundbreaking in 1986 Paul